Clark, R E <br/><br/>
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein.  [electronic resource] 

 -  Blood  Nov 2001 
 - 2887-93 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood.v98.10.2887  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amino Acid Sequence<br/>Antigen Presentation<br/>Antigens, Neoplasm--chemistry<br/>Antigens, Surface--chemistry<br/>Female<br/>Fusion Proteins, bcr-abl--chemistry<br/>HLA-A3 Antigen--genetics<br/>Humans<br/>K562 Cells--immunology<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--chemistry<br/>Neoplastic Stem Cells--immunology<br/>Peptide Fragments--chemistry<br/>Recombinant Fusion Proteins--immunology<br/>Spectrometry, Mass, Electrospray Ionization<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transfection